Valion Bio (VBIO) News
NASDAQ: VBIOHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
VBIO news summary
We found 5 recent headlines mentioning Valion Bio (VBIO): 1 in the past week and 4 in the past 30 days, most often from Nasdaq. VBIO is making an outsized move today, down 10.98% at $0.4806, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Tivic Health Systems, Inc. Stockholders Approve Reverse Stock Split Authority and 272,000 Share Increase to Equity Incentive Plan", was published by Nasdaq on Nov 17, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Valion Bio headlines
- Tivic Health Systems, Inc. Stockholders Approve Reverse Stock Split Authority and 272,000 Share Increase to Equity Incentive PlanTivic Health Systems, Inc. (reported as Valion Bio, Inc. in the filing) held a special meeting of stockholders on November 12, 2026. At the meeting, stockholders approved a proposal granting…Nasdaq
- Tivic Health Systems, Inc. Announces $700,000 Closing Under Series B Preferred Purchase AgreementTivic Health Systems, Inc. (operating as Valion Bio, Inc.) entered into a letter agreement on November 6, 2026, designated as the Fifth 3i Side Letter, with 3i, LP. Under this agreement, 3i, LP…Nasdaq
- Tivic Health Systems, Inc. Enters Side Letters for $50,000 Series B and $4,717,717.61 Series C Preferred Stock ClosingsTivic Health Systems, Inc., which filed under the name Valion Bio, Inc., is party to a Securities Purchase Agreement with 3i, LP, dated April 29, 2025, and amended as of December 9, 2025. This…Nasdaq
- Tivic Health Systems, Inc. Subsidiary Velocity Bioworks Receives Unsolicited Acquisition InterestTivic Health Systems, Inc., filing as Valion Bio, Inc., announced on October 26, 2026, that it has received unsolicited acquisition inquiries from independent third parties concerning its wholly…Nasdaq
- Tivic Health Systems, Inc. Interim CEO Dean Zikria Outlines Strategic Priorities and 30-Day AgendaTivic Health Systems, Inc. (disclosed in the filing as Valion Bio, Inc.) announced that Interim Chief Executive Officer Dean Zikria has established a strategic agenda following his first 30 days in…Nasdaq